[Skip to Content]
[Skip to Content Landing]
Views 253
Citations 0
News From the Food and Drug Administration
February 21, 2017

Inspections Turn up Insects, Mold in Drug Compounding Facilities

JAMA. 2017;317(7):688. doi:10.1001/jama.2017.0453

Since 2013 when Congress amended the Federal Food, Drug, and Cosmetic Act to address serious safety issues surrounding compounded drugs, the FDA has inspected hundreds of facilities and issued dozens of warnings to protect consumers from contaminated compounded products.

Lawmakers passed the amendment in response to a 2012 fungal meningitis outbreak that resulted from injectable methylprednisolone acetate distributed nationally by the New England Compounding Center in Framingham, Massachusetts. The outbreak caused 753 fungal infections and 64 deaths in 20 states, according to the US Centers for Disease Control and Prevention.

First Page Preview View Large
First page PDF preview
First page PDF preview
×